Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Humbert (Clamart, France). Inflammatory pathways leading to pulmonary arterial hypertension in connective tissue diseases. Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases

Member's Comments

No comment yet.

Related content which might interest you: Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Pulmonary arterial hypertension in connective tissue diseases Source: Eur Respir Mon 2012; 57: 42-57 Year: 2012 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Autoantibodies are frequently found in arterial and chronic thrombotic pulmonary hypertension not associated to connective tissue diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Inflammation in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 358-363 Year: 2003 Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1602493; 10.1183/13993003.02493-2016 Year: 2017 Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience Year: 2008 Exercise training in pulmonary arterial hypertension associated with connective tissue diseases Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Features of pulmonary involvement in patients with diffuse connective tissue diseases Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients Source: Eur Respir J 2014; 44: 963-972 Year: 2014 Women: lung and autoimmune disease Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=190 Year: 2003 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017 Year: 2018 Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Pulmonary vascular diseases Source: ERS Course 2015 Year: 2015 Pulmonary vascular diseases Source: ERS Skills Course 2016 Year: 2016